- Home
- PAYO vs RNA Comparison
PAYO vs RNA Comparison
Compare PAYO & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYO
- RNA
- Stock Information
- Founded
- PAYO 2005
- RNA 2012
- Country
- PAYO United States
- RNA United States
- Employees
- PAYO N/A
- RNA N/A
- Industry
- PAYO EDP Services
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- PAYO Technology
- RNA Health Care
- Exchange
- PAYO Nasdaq
- RNA Nasdaq
- Market Cap
- PAYO 3.6B
- RNA 3.7B
- IPO Year
- PAYO N/A
- RNA 2020
- Fundamental
- Price
- PAYO $9.85
- RNA $31.12
- Analyst Decision
- PAYO Strong Buy
- RNA Strong Buy
- Analyst Count
- PAYO 8
- RNA 10
- Target Price
- PAYO $12.00
- RNA $65.80
- AVG Volume (30 Days)
- PAYO 2.1M
- RNA 1.3M
- Earning Date
- PAYO 02-27-2025
- RNA 03-07-2025
- Dividend Yield
- PAYO N/A
- RNA N/A
- EPS Growth
- PAYO 118.00
- RNA N/A
- EPS
- PAYO 0.34
- RNA N/A
- Revenue
- PAYO $940,297,000.00
- RNA $10,117,000.00
- Revenue This Year
- PAYO $17.59
- RNA N/A
- Revenue Next Year
- PAYO $8.06
- RNA N/A
- P/E Ratio
- PAYO $29.57
- RNA N/A
- Revenue Growth
- PAYO 18.97
- RNA N/A
- 52 Week Low
- PAYO $4.22
- RNA $13.73
- 52 Week High
- PAYO $11.29
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- PAYO 39.56
- RNA 44.06
- Support Level
- PAYO $9.86
- RNA $31.14
- Resistance Level
- PAYO $11.19
- RNA $33.37
- Average True Range (ATR)
- PAYO 0.36
- RNA 1.67
- MACD
- PAYO -0.06
- RNA -0.16
- Stochastic Oscillator
- PAYO 0.74
- RNA 11.27
About PAYO Payoneer Global Inc.
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started to empower global commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.